NestLens
Investment Fund

Warburg Pincus Global Growth 14

Overview

Warburg Pincus Global Growth 14, L.P. (WPGG 14) is the fourteenth global flagship growth-equity fund raised by Warburg Pincus, the New York-based private equity firm founded in 1966. Fundraising launched in 2021 with a stated target of $16.0 billion; an interim close of $15.4 billion was reported in late January 2023 (Reuters/Yahoo Finance), before the GP announced final close on October 10, 2023 with $17.3 billion in total capital commitments — above target and above the firm's prior global flagship, Warburg Pincus Global Growth (2018 vintage, $15.0 billion) — making WPGG 14 the largest single fundraise in the firm's 57-year history at the time (note: a separate, non-Global-Growth-series fund, Warburg Pincus Private Equity X, had raised $15.1 billion in 2007, so "largest ever" claims should be read as largest-ever-firmwide per the GP's own press materials, not merely largest-in-the-Global-Growth-series). The vehicle is structured with parallel/feeder entities registered as Delaware limited partnerships and disclosed to the SEC via Form D exempt-offering notices, including Warburg Pincus Global Growth 14 Partners, L.P. (CIK 1906942), Warburg Pincus Global Growth 14-B, L.P. (CIK 1906960), and Warburg Pincus Global Growth 14-E, L.P. (CIK 1906976). Per the GP's own announcement, the strategy is thesis-driven, sector-diversified growth investing pursued globally across the firm's core industry groups, rather than a single-sector or single-geography mandate. Executives quoted in the close announcement: Chip Kaye (CEO) on fundraising demand from existing and new investors, Timothy Geithner (Chairman) on diversification/discipline, and Jeff Perlman (President) on market positioning. Warburg Pincus disclosed the fund's LP base primarily by category — a mix of public and private pension funds, sovereign investors, insurance companies, endowments, foundations, funds of funds, family offices, and high-net-worth individuals — without naming specific institutional backers or commitment amounts in its own materials. One specific LP has surfaced in third-party fund-database indexing (PitchBook's LP-commitment tracking, echoed in aggregated search summaries): Anne Arundel County (Maryland) Retirement and Pension System, listed as one of 48 tracked limited partners with an original commitment dated October 10, 2023 — this is a database-sourced data point, not a GP or LP self-disclosure, and the commitment amount is not disclosed; treat as plausible-but-unconfirmed-from-a-primary-source. The GP has publicly attributed the following portfolio investments to this fund: Simtra BioPharma Solutions (formerly Baxter's BioPharma Solutions business), Ensemble Health, EverBank, Internet Brands, Norstella, Oona Insurance, ParetoHealth, Watertec India, and — newly confirmed this pass via a dated Warburg Pincus press release — Enovo Life Sciences (a biologics/advanced-therapies platform launched October 7, 2024 with founders Mario Philips and Roel Gordijn, funded out of WPGG 14). Note: Warburg Pincus's 2023 PacWest Bancorp/Banc of California $400M equity investment and its 2025-26 Clearwater Analytics take-private are both real Warburg Pincus deals but could NOT be confirmed as WPGG 14 investments — Clearwater Analytics is explicitly tied to the successor fund, Warburg Pincus Global Growth 15, in SEC proxy filings, so it should NOT be listed as a WPGG 14 portfolio company. No IRR, TVPI, DPI, or other performance metrics for WPGG 14 are publicly available (PitchBook has a fund-performance page but the actual return figures sit behind its paywall); the only public performance data point findable relates to the prior fund (Global Growth, 2018 vintage), reported at ~19.12% net IRR as of mid-2022 — this is NOT a WPGG 14 metric and is included only for context, not as this fund's performance. Kirkland & Ellis LLP served as legal counsel on the fund's formation/closing.

Key Facts

Fund type
Private Equity
Vintage year
2021
Strategy
Global Growth
Managed by
Warburg Pincus
Fund size
USD 17.3B
Visit website ↗View full profile on NestLens →

Related on NestLens

Last updated July 8, 2026